Tadiran Batteries wins $30m. deal

The deal follows a previous order by Neptune for PulsePlus valued at $5m.

By AVI KRAWITZ
December 8, 2005 06:33

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Tadiran Batteries Ltd. said Wednesday it won a four-year contract worth $30 million to supply lithium batteries to Neptune Technology Group Inc., a US-based manufacturer of Automatic Meter Reading devices for water utilities. Tadiran, a subsidiary of Saft Group SA, said it would supply Neptune with the PulsesPlusTM battery system consisting of Tadiran's lithium thionyl chloride batteries combined with its new Hybrid Layer Capacitor technology. The battery can provide 10 to 20 years of operating life under extreme conditions. The deal follows a previous order by Neptune for PulsePlus valued at $5m.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS